US Material Events SEC 8-K Filings — April 03, 2026

03-04-2026

NexPoint Real Estate Finance Operating Partnership, L.P. (OP) provided an additional $6.0 million loan on March 30, 2026, under the existing NSP Note to NSP OC and co-borrowers, increasing the outstanding principal to $22.7 million as of April 3, 2026, out of a $40.0 million facility bearing 14% PIK interest maturing January 16, 2031. Portions of the loan and second funding were participated by OSL ($7.5 million), HFRO ($2.5 million), NXDT ($962,000), HGLB ($1.25 million), and NRES ($38,000). The Company holds 25.4% ownership in NSP common stock with guarantees capped at $97.6 million, and affiliates own substantially all NSP equity.

• ·NSP Note is secured by first priority lien on certain income streams and related deposit accounts of co-borrowers.
• ·Interest on NSP Note is payable in kind (PIK), interest-only, maturing January 16, 2031.
• ·NSP Note Purchasers and OSL have right but not obligation to participate pro rata in future advances; OP funds remainder.
• ·Accounts advised by Sponsor and affiliates own substantially all NSP equity securities.

03-04-2026

On March 31, 2026, MercadoLibre's Board established performance goals under the 2026 Bonus Program for five NEOs, tying bonuses to metrics including net revenues, financial income, operating income, adjusted total payment volume, and Competitive Net Promoter Score, with target bonuses at 33.33% of annual base salary adjustable by +/-50% based on individual performance. The Board also adopted the 2026 Long Term Retention Program, setting target awards totaling $41,500,000 for the NEOs payable annually over six years (first payment January-April 2027), comprising fixed payments and stock price-linked components. No declines or flat metrics reported in performance goals.

• ·Bonus metrics in constant dollars: Net revenues and financial income, Income from operations, Total payment volume-adjusted (excluding P2P), Competitive Net Promoter Score.
• ·LTRP Grant Date: January 1, 2026; payments subject to continued employment; stock price based on average closing price over final 60 trading days of prior year.
• ·Exhibit 10.1: Full 2026 LTRP document filed.

03-04-2026

Healthier Choices Management Corp. entered into an unsecured Loan Agreement with Sabby Volatility Warrant Master Fund, Ltd. on March 27, 2026, for general working capital purposes, as disclosed in an 8-K filing on April 3, 2026. The agreement provides for Advances via promissory Notes with a Scheduled Maturity Date of December 31, 2026, potentially extendable. No specific loan amounts, interest rates, or financial metrics are detailed in the provided filing excerpt.

• ·Loan is unsecured (Section 4.1).
• ·Scheduled Maturity Date: December 31, 2026 (potentially extendable per Section 2.4).
• ·SEC 8-K Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Exhibits).

03-04-2026

Health Catalyst, Inc. entered into a Transition Agreement with former CEO Daniel Burton on March 31, 2026, following his accelerated retirement from the CEO position on February 12, 2026, as previously reported in a Form 8-K on February 18, 2026. Under the agreement, Burton will serve as a strategic advisor until December 31, 2026, receiving an average monthly base salary of $10,000 starting March 1, 2026, in exchange for forfeiting all unvested restricted stock units eligible for vesting after March 2, 2026, and providing a general release of claims. This arrangement facilitates a smooth transition of his prior responsibilities.

• ·Transition Agreement dated March 31, 2026, attached as Exhibit 10.1
• ·Previous Form 8-K filed February 18, 2026, regarding Burton's retirement notice on February 12, 2026
• ·Strategic advisor role ends December 31, 2026

03-04-2026

Atlantic International Corp. received default notices from SPP Credit Advisors on March 30, 2026, under the April 2025 Financing Agreement and June 2024 Bridge Loan, alleging covenant breaches, prompting SPP to reserve rights to accelerate obligations, exercise pledges over Lyneer subsidiaries, and replace management. The company disputes the defaults, claiming the debt (less than $50M) was satisfied via SPP's sale of over $77M in shares, and filed a lawsuit on April 1, 2026, seeking an injunction against SPP's actions. COO Mathew Evelt resigned the same day but was terminated for cause after allegedly joining SPP.

• ·SPP default notices dated March 30, 2026, did not demand repayment or include payoff amounts.
• ·Company is an emerging growth company trading as ATLN on Nasdaq Global Market.
• ·Lawsuit filed April 1, 2026, in Supreme Court of New York, County of New York.

03-04-2026

Ashford Inc. and Ashford Hospitality Advisors LLC notified Braemar Hotels & Resorts Inc. on March 31, 2026, of their election to extend the Fifth Amended and Restated Advisory Agreement (dated April 23, 2018) for an additional successive 10-year term, commencing January 24, 2027, and ending January 24, 2037, on the same terms and conditions. The extension is exercised pursuant to Section 12.2 of the agreement, subject to rights under Section 6.6, with prior Letter Agreements from August 26, 2025, and December 22, 2025, remaining in full force.

• ·Notice delivered via hand delivery and email at least 210 days prior to initial term expiration.
• ·Advisory Agreement initial term expires January 24, 2027.
• ·Extension right allows up to seven successive 10-year terms.

03-04-2026

United Homes Group, Inc. entered into the Fifth Amendment to its Wells Fargo Credit Agreement and the Second Amendment to its Kennedy Lewis Credit Agreement on March 31, 2026, waiving Debt Service Coverage Ratio and Leverage Ratio covenant requirements temporarily until the earlier of May 31, 2026 or an unrelated Event of Default, to facilitate its pending merger with Stanley Martin Homes, LLC. These waivers provide short-term relief but are conditional; if the merger fails to close by the May 31 Outside Date, the Company must refinance both facilities and repay obligations in full within 60 days.

• ·WF waiver applies from Fifth Amendment Effective Date (March 31, 2026) until May 31, 2026 or unrelated Event of Default.
• ·KL waiver applies specifically from January 1, 2026 through fiscal quarter ending March 31, 2026.
• ·Exhibits filed: 10.1 (Fifth Amendment to WF Credit Agreement), 10.2 (Second Amendment to KL Credit Agreement).

03-04-2026

Village Farms International, Inc. (VFF) announced a succession plan for Chief Financial Officer Stephen Ruffini, who will transition after 17 years of service to a new role leading M&A activities, remaining as CFO until a permanent replacement is identified. The company highlighted its strong financial position and growth strategy combining organic investments with accretive acquisitions. CEO Michael DeGiglio commended Ruffini's contributions, including NASDAQ uplisting and cannabis expansion.

• ·Hired as CFO in 2009; instrumental in NASDAQ uplisting, debt/equity financings, and cannabis expansion.
• ·Operates EU-GMP certified cannabis facility in Delta, British Columbia, exporting to international medical markets.
• ·Clean Energy division transforms landfill gas into renewable natural gas.

03-04-2026

On April 2, 2026, the Board of Forum Markets, Incorporated (formerly ETHZilla Corp) approved equity awards under the 2025 Omnibus Incentive Plan to CEO and Chairman McAndrew Rudisill and CFO John Saunders to aid retention and align interests with shareholders. Rudisill received a one-time initial award with a grant date value of $4,285,500 (two times the anticipated annual award of $2,142,750) and a pro-rated 2025 award of $898,194, while Saunders received an award valued at $750,000. Each award comprises 60% performance stock units (PSUs) vesting on share price hurdles of $5.00, $7.50, and $10.00, and 40% restricted stock units (RSUs) vesting over three years from August 1, 2025.

• ·A prior grant of 136,500 shares of restricted common stock to McAndrew Rudisill on November 12, 2025, was rescinded by the Board on December 1, 2025, with his approval.
• ·PSUs vest in one-third tranches upon share price hurdles of $5.00 (min 1-year service), $7.50 (min 2-year), $10.00 (min 3-year), achieved if closing price met for 30 trading days in any 60-day period within 5 years; unachieved PSUs forfeit.
• ·RSUs vest in one-third installments on the first, second, and third anniversaries of August 1, 2025, subject to continued employment.
• ·Awards include accelerated vesting provisions on termination without Cause pre-Change in Control or post-Change in Control termination without Cause or for Good Reason.

03-04-2026

Entera Bio Ltd. entered into a Securities Purchase Agreement on April 1, 2026, with funds affiliated with BVF Partners LP for a private placement of 7,827,789 units at $1.2775 per unit, generating approximately $10.0 million in gross proceeds upon closing on April 2, 2026. Each unit consists of one Ordinary Share (or Pre-Funded Warrant) and one Ordinary Share Warrant to purchase 1.5 Ordinary Shares at $1.24 per share, exercisable after six months and expiring in five years; full exercise could yield additional $14.5 million. Proceeds will support the phase 3 registrational study of EB613 for postmenopausal osteoporosis and general working capital.

• ·Ordinary Share Warrants exercisable six months after April 2, 2026 closing and expire five years from issuance.
• ·Registration Rights Agreement requires SEC registration statement filing no later than 30 days after April 2, 2026.
• ·Pre-Funded Warrants exercisable immediately at NIS 0.0000769 per share with no expiration date.

03-04-2026

Ensysce Biosciences, Inc. announced the resignation of Curtis Rosebraugh from its Board of Directors, effective April 1, 2026; he had served on the Nominating and Corporate Governance Committee. The resignation notice is attached as Exhibit 17. No additional details on reasons or successor were provided in the filing.

• ·Resignation notice dated and effective April 1, 2026; Form 8-K filed April 3, 2026
• ·Common Stock trades as ENSC on Nasdaq

03-04-2026

On March 30, 2026, Fidelity National Information Services, Inc. (FIS) was notified that Board Director Mark Benjamin will not stand for re-election at the 2026 annual meeting of shareholders, a decision not due to any disagreement with the Company's operations, policies, or practices. In connection with his departure, the Board approved reducing its size from ten to nine directors, effective immediately following the 2026 Shareholder Meeting. FIS's CEO Stephanie Ferris thanked Mr. Benjamin for his extraordinary contributions and dedication.

• ·Mr. Benjamin’s decision was not due to any disagreement with the Company on any matters relating to the Company’s operations, policies, or practices.

03-04-2026

Safe Pro Group Inc. appointed Jarret Mathews as Chief Operating Officer effective April 1, 2026, with an annual base salary of $200,000, a $50,000 commencement bonus, $1,000 monthly home-office allowance, and eligibility for up to 100% bonus plus equity grants including 20,000 inducement shares and performance options tied to revenue milestones. The company also amended CFO Theresa Carlise's employment agreement effective the same date, increasing her base salary to $225,000, adding a $1,000 monthly automobile allowance, and providing full health insurance coverage or a $2,000 monthly medical allowance. No performance declines or financial metrics were reported.

• ·Jarret Mathews' employment term is initially two years, auto-renewing annually with 30 days' notice of non-renewal.
• ·Mr. Mathews, age 50, previously led Phase Zero Consulting since July 2024 and served in the US Army as Director, Joint Acquisition Task Force from July 2021 to July 2024.
• ·No family relationships or arrangements influencing Mr. Mathews' selection; no material related transactions under Item 404(a).
• ·Exhibits 10.1 (Mathews Employment Agreement) and 10.2 (Carlise Amendment) filed with the 8-K.

03-04-2026

Ian T. Clark resigned from GoodRx Holdings, Inc.'s Board of Directors, including the Nominating & Governance Committee, effective March 31, 2026, with no disagreement on operations, policies, or practices. To achieve balanced membership across director classes post-resignation, the Board moved Wendy Barnes (CEO, President, and Director) from Class I (term expiring 2027) to Class III (term expiring 2026) via resignation and re-election on April 1-2, 2026, maintaining her uninterrupted service. The Board now consists of three directors in each of Classes I, II, and III.

• ·Filing signed on April 3, 2026

03-04-2026

On March 31, 2026, Ms. Betsy Atkins resigned from the Board of Directors of Rackspace Technology, Inc. The resignation did not result from any dispute or disagreement with the Company or the Board on any matter relating to the Company's operations, policies, or practices. The 8-K filing was submitted on April 3, 2026.

03-04-2026

NexPoint Diversified Real Estate Trust OP, L.P. (the OP) entered into a Side Letter on April 3, 2026, effective March 30, 2026, purchasing a $962,000 undivided participation interest in the NSP Note from NREF; the NSP Note has a $40 million aggregate principal capacity with $22.7 million outstanding as of April 3, 2026, bears 14% per annum PIK interest, and matures January 16, 2031. The note is secured by a first priority lien on certain income streams and deposit accounts of the co-borrowers, who are affiliates of the Company's Sponsor. The Company owns approximately 53.02% of NSP's common stock and has guaranteed certain NSP obligations.

• ·NSP Note dated January 16, 2026, amended March 25, 2026; interest-only payments.
• ·OP, HFRO, HGLB, NRES, and OSL have right but not obligation to participate pro rata in future advances under NSP Note.
• ·Each Other NSP Note Purchaser and NREF advised or managed by affiliate of Company's Adviser; OSL deemed affiliate through common ownership.

03-04-2026

On April 3, 2026, the Compensation Committee of Oil-Dri Corporation of America approved the Second Amendment to the 2005 Deferred Compensation Plan, which updates the definition of Eligible Employee or Director to align with current salary grades, clarifies Separation from Service, and changes Earnings crediting to at least quarterly. The Committee also approved amended forms of restricted stock agreements for Class A Common Stock, Common Stock, Class B Stock (employees), and Common Stock (directors) under the 2006 Long-Term Incentive Plan to better align with current practices. No financial impacts or performance metrics were disclosed.

03-04-2026

Drugs Made in America Acquisition Corp II (DMIIU) entered into a Definitive Investment and Sponsor Transition Agreement on March 23, 2026, with Tal Alpha Yezum Vekidum Asakim (2003) LTD for a total financing commitment of $1,400,000 to fund audit, SEC filings, Nasdaq fees, legal costs, and de-SPAC transaction preparation. Of this, $150,000 has been received, $300,000 is due by March 30, 2026, and $950,000 is reserved in escrow; however, the existing sponsor is described as non-performing and subject to legal constraints, necessitating a transition facilitated by the Company. The agreement includes a 4-month timeline to execute an investor-introduced transaction agreement in principle and 6-month exclusivity, with convertible notes at a 35% discount to post-merger market value.

• ·Exclusivity period: 6 months
• ·Timeline: Execute agreement in principle within 4 months
• ·Investor right of first refusal on additional capital beyond $1.4M
• ·No claim on trust account for convertible notes
• ·Maturity of Interim Convertible Note: 9 months from issuance
• ·Governing law: Cayman Islands
• ·Prior agreements superseded: LOI dated March 5, 2026; Addendum No. 1 dated March 9, 2026; Interim Convertible Note dated March 9, 2026; Sponsor Standstill Agreement dated March 18, 2026

03-04-2026

Soluna DV Wind SponsorCo, LLC, an affiliate of Soluna Holdings, Inc., has entered into a Membership Interest Purchase Agreement dated April 1, 2026, to acquire all equity interests in Briscoe Wind Farm, LLC from sellers Briscoe Wind Project Holdings I, LLC, JPM Capital Corporation, and Morgan Stanley Wind LLC. The target company owns an approximately 150-megawatt nameplate capacity wind generation project located in Briscoe County and Floyd County, Texas. No purchase price or financial terms are disclosed in the filing.

• ·Agreement execution date: April 1, 2026
• ·SEC 8-K filing date: April 03, 2026
• ·Project locations: Briscoe County and Floyd County, Texas

03-04-2026

Inflection Point Acquisition Corp. V entered into Amendment No. 2 to its Promissory Note with Inflection Point Fund I LP on April 2, 2026, increasing the principal amount from $700,000 to $800,000 to provide additional working capital. This follows an original note dated February 12, 2025, for up to $500,000 (fully advanced) originally from Maywood Sponsor, LLC and assigned to the Payee on September 9, 2025, with a first amendment on January 7, 2026, raising it to $700,000. No other changes to the note terms were made.

• ·Promissory Note originally executed by Maywood Acquisition Corp. (former name of Inflection Point Acquisition Corp. V)
• ·Governed by the laws of the State of New York
• ·SEC 8-K filed on April 03, 2026, covering Items 1.01, 2.03, and 9.01

03-04-2026

Blue Owl Digital Infrastructure Operating Partnership LP (as Parent) and BODIT SPV LLC (as Borrower) entered into a Revolving Credit Agreement dated April 1, 2026, with Bank of America, N.A. as Administrative Agent and Collateral Agent, and Bank of America Securities, Inc. as Lead Arranger and Bookrunner. The agreement provides for revolving credit loans for working capital, general corporate purposes, capital expenditures, and acquisition of data center-related properties, along with letters of credit up to an aggregate of $100,000,000. No specific revolving credit commitment amounts are detailed in the provided filing excerpt.

• ·Filing Date: April 03, 2026
• ·Agreement effective date: April 1, 2026
• ·SEC Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 9.01 (Exhibits)

03-04-2026

At the NeuroOne Medical Technologies Corporation annual stockholder meeting on April 3, 2026, with 30,272,834 shares present representing 59.72% quorum, shareholders elected Jeffrey Mathiesen and Edward Andrle as Class III directors for three-year terms, ratified Baker Tilly US, LLP as independent auditors for FY ending September 30, 2026, approved a reverse stock split amendment at a 1-for-2 to 1-for-15 ratio at Board discretion, and approved the First Amendment to the 2025 Equity Incentive Plan increasing the share reserve by 1,500,000 new shares to 4,500,000 plus a 5% annual evergreen increase for five years starting 2027. All proposals passed with majority votes, however Proposal 4 (equity plan) received 3,415,319 votes against and 11,393,265 broker non-votes, while director elections saw some withheld votes (494,745 for Mathiesen, 705,164 for Andrle). Proposal 5 authorizing adjournments also passed overwhelmingly.

• ·Proposal 2 (auditor ratification): 30,031,054 For; 70,706 Against; 171,074 Abstain.
• ·Proposal 3 (reverse stock split): 28,408,499 For; 1,780,031 Against; 84,304 Abstain.
• ·Proposal 4 (equity plan): 15,146,194 For; 3,415,319 Against; 318,056 Abstain; 11,393,265 Broker Non-Votes.
• ·Proposal 1 (directors): Jeffrey Mathiesen - 18,384,823 For; Edward Andrle - 18,174,404 For.
• ·Proposal 5 (adjournment): 29,020,938 For; 1,067,842 Against; 184,052 Abstain.
• ·Equity plan evergreen: automatic annual increase of 5% of Fully Diluted Shares on Jan 1 from 2027-2031, subject to Board reduction.

03-04-2026

Kezar Life Sciences, Inc. entered into a Lease Termination Agreement effective April 1, 2026, for approximately 47,714 rentable square feet (24,357 sq ft on the 3rd floor and 23,357 sq ft on the 4th floor) at 4000 Shoreline Court, San Francisco, California, originally leased since August 16, 2017. The company paid a termination fee of $1,318,453.88 to Landlord GNS South Tower, LP, representing the remaining rent obligation of $1,984,536.88 less the security deposit of $666,083.00 (after $7,600.00 retained for repairs). Parties exchanged mutual releases, with no reconciliation of 2026 operating expenses, tax expenses, or utilities costs.

• ·Lease originally dated August 16, 2017, amended November 1, 2022.
• ·Agreement executed April 1, 2026; filed April 03, 2026.
• ·Tenant must complete Surrender Obligations by Termination Date, including walk-through inspection option.
• ·No further liability post-termination except surviving obligations; governed by California law.

03-04-2026

On April 2, 2026, Gibraltar Industries, Inc.'s Compensation and Human Capital Committee approved special discretionary cash bonuses totaling $528,584 to four named executive officers, equal to 75% of their 2025 target bonuses under the MICP (in addition to the 25% already earned), recognizing efforts on multiple acquisitions, Renewables business divestiture preparation, and OmniMax integration. The bonuses are contingent on one-year continued employment in good standing, with repayment required if an officer resigns or is terminated for cause before the anniversary. No performance declines or flat metrics were noted in the context of these awards.

• ·Special Bonuses approved for year ended December 31, 2025 performance.
• ·Repayment required within 30 days if officer resigns or is terminated for cause before one-year anniversary of approval.
• ·Company may deduct unpaid bonus amounts from amounts owed to officer upon separation.

03-04-2026

On April 1, 2026, ClearOne, Inc. entered into a letter agreement with Derek L. Graham for his continued service as CEO on a transitional consulting basis after his prior employment agreement expired on March 31, 2026. Under the agreement, Mr. Graham will provide up to 10 hours per week of consulting services at $160 per hour while performing all CEO functions, with no fixed term and terminable by either party at any time. The full letter agreement is filed as Exhibit 10.1.

• ·Letter agreement filed as Exhibit 10.1
• ·Event reported date: April 3, 2026 (earliest event: April 1, 2026)

03-04-2026

HF Foods Group Inc. and its subsidiaries entered into Joinder and Amendment No. 5 to the Third Amended and Restated Credit Agreement dated March 31, 2022, effective March 30, 2026, adding HF Atlanta, LLC as a new Working Capital Borrower. The amendment restates certain schedules and the Commitment Schedule, with no specific changes to financial terms disclosed in the filing. No performance metrics or quantitative impacts are provided.

• ·Original Credit Agreement dated March 31, 2022.
• ·Amendment effectiveness subject to no Default or Event of Default before or after.
• ·Governing law: State of Illinois.

03-04-2026

On March 31, 2026, Skye Bioscience, Inc. repriced all outstanding stock options for current full-time employees and executives, covering 2,420,978 shares, to a new exercise price of $0.6150 per share from prior ranges of $1.055 to $14.56, aiming to retain and motivate personnel without dilution or additional cash costs. The Board also appointed John P. Sharp as Chief Financial Officer effective immediately via a Master Services Agreement with Lohman & Associates, billing at a flat rate of $25,600 for up to 64 hours per month. Punit Dhillon (CEO) holds 1,103,959 repriced options and Tuan Diep (COO) holds 396,295 repriced options.

• ·Repriced options granted prior to December 31, 2025 under the 2014 Omnibus Plan or 2024 Inducement Plan.
• ·John P. Sharp's prior roles: CFO at SaNOtize (Dec 2022-Oct 2025), PhaseBio (Apr 2016-Nov 2022), HUYA (Mar 2014-Dec 2015), Ligand (Apr 2007-Mar 2014); former auditor at PricewaterhouseCoopers LLP.
• ·No family relationships or related party transactions for Mr. Sharp under Items 401(d) or 404 of Regulation S-K.

03-04-2026

Hennessy Capital Investment Corp. VII (HVIIU) filed a Form 8-K on April 03, 2026, disclosing entry into a material definitive agreement under Item 1.01, along with Regulation FD disclosure under Item 7.01. Exhibit 99.1 provides further details on the matter. No financial metrics or performance data were included in the provided filing content.

• ·Filing Items: 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• ·Exhibit: 99.1 attached

03-04-2026

FreeCast, Inc. amended its Equity Purchase Agreement with Amiens Technology Investments LLC, originally dated December 8, 2025, on March 30, 2026. Key changes include extending the Pricing Period to 10 Trading Days, requiring a Registration Statement filing within 30 days of the Effective Date with effectiveness targeted within 90 days, and structuring a 1.5% Commitment Fee as Commitment Shares issued in thirds upon the first Closing, after $15.0 million in aggregate Share purchases, and after $30.0 million in purchases.

• ·Pricing Period redefined as the Trading Day following Advance Notice Date to 4:00 p.m. NYC time on the 10th Trading Day thereafter.
• ·Registration Statement must be filed within 30 days of Effective Date, effective within 90 days, and maintained until all Registrable Securities sold or eligible under Rule 144.
• ·Commitment Shares priced at the lower of $10.00 or lowest daily VWAP over prior 5 Trading Days; automatic issuance on breach of certain covenants.

03-04-2026

TransAct Technologies Incorporated entered into Amendment No. 6 to its lease agreement with Bomax Holdings LLC on March 31, 2026, extending the term for its primary operating facility at 20 Bomax Drive, Ithaca, New York, from April 1, 2026, through September 30, 2031 (5 years and 6 months). Monthly base rent decreases initially to $40,022.13 for the first two years from the prior $43,100.75 (approximately 7% reduction), providing cost savings. However, rent escalates annually thereafter to a maximum of $43,347.04 in the final period, and the landlord gains a recapture right for up to 18,000 sq ft of warehouse/manufacturing space, 9,000 sq ft of office space, and unused outdoor space.

• ·Landlord's recapture right exercisable with 6 months' notice; tenant must vacate within 3-6 months.
• ·Parking rights from original lease restored; landlord responsible for driveway/parking lot capital improvements.
• ·Existing 1-year extension option deleted.

03-04-2026

Aurinia Pharmaceuticals Inc. (AUPH) announced a definitive merger agreement to acquire Kezar Life Sciences, Inc. (KZR) for $6.955 in cash per share plus a non-transferable contingent value right (CVR) linked to zetomipzomib development milestones, collaborations with Everest Medicines and Enodia Therapeutics, and net cash exceeding $50 million. The tender offer is set to commence by April 13, 2026, with closure expected in Q2 2026, supported by Tang Capital Partners (9.0% owner). While offering shareholder liquidity and strategic expansion in autoimmune therapies, the deal faces risks including closing conditions, potential delays, or termination.

• ·Tender offer requires majority of Kezar shares tendered and other customary conditions.
• ·Kezar board unanimously approved the merger following strategic review.
• ·Positive FDA Type C meeting interactions for zetomipzomib in AIH.

03-04-2026

David Chang resigned from the Board of Directors of Battalion Oil Corporation, including his role as Chairman of the Compensation Committee, effective March 31, 2026, and stated he will not stand for re-election. The resignation is explicitly not due to any disagreement with the Company on matters related to operations, policies, or practices.

• ·Resignation letter dated March 30, 2026
• ·Company address: 820 Gessner Road Suite 1100, Houston, Texas 77024

03-04-2026

Firefly Aerospace amended its Credit Agreement, increasing the Revolving Credit Facility commitments by $45 million to a total of $305 million, providing additional liquidity but at a higher interest spread increased by 0.25% (now term SOFR + 3.25% or ABR + 2.25%). The amendment removed the minimum free cash flow covenant but imposed a stricter minimum liquidity covenant of $381.25 million monthly starting April 30, 2026. Director Marc Weiser resigned effective April 2, 2026, with no disagreements noted, and the 2026 Annual Meeting was set for June 4, 2026, with proposal deadlines of April 13, 2026.

• ·Revolving Credit Facility matures on August 8, 2028.
• ·Credit Agreement originally dated August 8, 2025.
• ·Stockholder proposals under Rule 14a-8 and advance notice bylaws due no later than April 13, 2026.
• ·Annual Meeting deadlines apply to nominations and proposals at principal executive offices: 2203 Scottsdale Drive, Leander, Texas 78641.

03-04-2026

On April 2, 2026, Tai A. Thornock, Chief Accounting Officer and principal accounting officer of Finance of America Companies Inc., notified the company of his retirement effective May 15, 2026; the departure was not due to any disagreement with management or the Board. Following his retirement, Matthew A. Engel, the Chief Financial Officer, will serve as the principal accounting officer in addition to his existing role as principal financial officer. Mr. Thornock may remain as a consultant for a transitional period, and the company expressed gratitude for his contributions.

• ·Filing date: April 3, 2026
• ·Company address: 5830 Granite Parkway, Suite 400, Plano, Texas 75024
• ·Class A Common Stock trading symbol: FOA on New York Stock Exchange

03-04-2026

Getty Images Holdings, Inc. appointed Jeffrey Titterton, a Board member since October 18, 2022, to its Audit Committee on April 3, 2026, determining he meets independence requirements under Rule 10A-3 and NYSE standards. James Quella resigned from the Board and Audit Committee effective April 1, 2026, with no disagreements on company operations, policies, or practices. The Board size remains at eleven directors, with the vacancy to be filled later.

• ·Jeffrey Titterton appointed to Board on October 18, 2022.
• ·James Quella resignation submitted March 31, 2026.
• ·Earliest event reported: March 29, 2026.

03-04-2026

Kinetik Holdings Inc. announced Amendment No. 2 to its Receivables Purchase Agreement (RPA), originally dated April 2, 2024 and previously amended April 1, 2025, effective March 31, 2026, primarily to extend the Scheduled Termination Date. The amendment involves Kinetik Receivables LLC as Seller, Kinetik Holdings LP as Servicer, PNC Bank as Administrative Agent and a Purchaser, with updates to schedules, exhibits, and forms including a new Commitment Increase Request form. No specific financial amounts, changes in commitments, or performance metrics were disclosed.

• ·Amendment includes amendments to Schedule I (Purchasers and Commitments), redesignation of Exhibit B to B-1, addition of new Exhibit B-2 (Form of Commitment Increase Request).
• ·Conditions to effectiveness require documents listed in Exhibit E.
• ·Governed by New York law.

03-04-2026

Mastech Digital, Inc. and CEO Nirav Patel agreed to pay his 2025 annual performance bonus of $616,932 in the form of 100,314 restricted shares, converted at a 30-day VWAP of $6.15, instead of cash. The shares vest immediately but are subject to a disposal prohibition until March 30, 2028, with restrictions lapsing upon separation, death, or disability. This is documented in a Restricted Stock Agreement dated March 30, 2026.

• ·Restricted shares subject to immediate vesting.
• ·Disposal prohibition until March 30, 2028, lapsing on separation from Company, death, or disability.
• ·Governed by Executive Employment Agreement dated November 1, 2024.

03-04-2026

On April 1, 2026, Mark Hilz, Chief Operating Officer, Corporate Secretary, and Board member of HeartSciences Inc., passed away at age 67 after a period of illness; he had served on the Board since 2013 and in his executive roles since March 2022. The company does not anticipate hiring a replacement COO or any disruptions to operations, as the MyoVista Insights™ platform has launched and the MyoVista® wavECG™ device was submitted for FDA 510(k) clearance in December 2025.

• ·Mr. Hilz was 67 years old at the time of his passing.
• ·MyoVista® wavECG™ submitted to FDA for 510(k) premarket clearance in December 2025.

03-04-2026

On April 3, 2026, SharpLink, Inc. entered into mutual termination agreements with Galaxy Digital Capital Management LP and ParaFi Capital LP, terminating asset management agreements dated May 30, 2025, for discretionary investment management services related to the Company's Ethereum purchases, effective May 31, 2026. No termination fees, penalties, or ongoing obligations remain, and the move reflects internal evolution with added personnel rather than any disagreements. The Company noted appreciation for the partners' prior contributions to its ETH treasury strategy.

• ·Original asset management agreements dated May 30, 2025.
• ·Termination Agreements' full texts to be filed as exhibits to Form 10-Q for quarter ending March 31, 2026.
• ·No material relationship currently exists between the Company and Galaxy or ParaFi.

03-04-2026

On April 2, 2026, Advanced Biomed Inc. (ADVB) entered into a Share Purchase Agreement to acquire 100% of the equity interest (10,000 ordinary shares) in Acellent Technologies (Hong Kong) Co. Limited, a provider of AI-powered financial verification and audit solutions, from seller Xiaomin Chen for 270,000 shares of ADVB common stock valued at $4.00 per share, totaling $1,080,000. The transaction closing is conditioned upon satisfactory financial and legal due diligence and receipt of all required regulatory approvals. No financial performance metrics or comparisons are provided in the filing.

• ·Target incorporated under laws of Hong Kong
• ·Closing date to be mutually agreed after conditions met
• ·ADVB is an emerging growth company

03-04-2026

Crown Reserve Acquisition Corp. I (SPAC), a Cayman Islands exempted company, entered into a Business Combination Agreement dated March 30, 2026, with CRAC Merger Sub Inc. and Carvix, Inc., providing for SPAC's domestication to Delaware followed by a merger where Merger Sub merges with Carvix, with Carvix surviving as SPAC's wholly-owned subsidiary. The transaction includes stockholder support agreements from key Carvix stockholders, plans for PIPE financing meeting a minimum investment amount and a committed ELOC, an Investor Rights Agreement, and earnout shares for eligible Carvix equityholders based on post-merger EBITDA and revenue performance over three years. All relevant boards have unanimously approved the agreement and recommended it to shareholders.

03-04-2026

Mobix Labs, Inc. entered into a securities purchase agreement with Leviston Resources, LLC on March 31, 2026, issuing a senior secured convertible promissory note with $3,000,000 principal for $2,550,000 cash, representing a discount. The note carries 10% annual interest and matures on July 31, 2026, with conversion into common stock possible at a discounted price (85% of lowest 8-day VWAP or March 31 closing price), posing dilution risk. The company agreed to file a registration statement within 14 days for resale of conversion shares, to be effective within 30 days.

• ·Note maturity date: July 31, 2026
• ·Registration Statement filing deadline: no later than 14 days following March 31, 2026
• ·Registration Statement effectiveness deadline: no later than 30 days following March 31, 2026
• ·Issuance relies on Section 4(a)(2) and Rule 506(b) of Regulation D exemptions
• ·Exhibits to be filed in next Form 10-Q

03-04-2026

Denali Therapeutics Inc. (Nasdaq: DNLI) regained full rights and control of investigational therapy DNL593 (PTV:PGRN) for GRN-related frontotemporal dementia (FTD-GRN) after Takeda terminated their co-development collaboration due to strategic considerations unrelated to efficacy or safety data. Denali plans to advance DNL593 independently using its TransportVehicle™ platform, with results from the ongoing Phase 1/2 study (enrollment complete with 40 participants) expected by end of 2026; interim data from healthy volunteers showed dose-dependent cerebrospinal fluid progranulin increases and good tolerability with no significant safety signals.

• ·Interim results from Part A of Phase 1/2 study in healthy volunteers: dose-dependent increases in cerebrospinal fluid progranulin levels, consistent with brain delivery; generally well tolerated with no significant safety signals.
• ·In animal models, TV platform enables 10- to 30-fold greater brain exposure for antibodies/enzymes; >1,000-fold for oligonucleotides in primates.
• ·FTD is most common dementia under age 60; GRN mutations are common genetic cause of FTD with no approved treatments to slow progression.

03-04-2026

On March 31, 2026, J. Mark Hemmann resigned from ESG Inc.'s Board of Directors and all committees, effective immediately, stating it was not due to any disagreement with the company's operations, policies, or practices. On April 1, 2026, the Board appointed Joseph F. Rossetti, age 43 with over 15 years in financial services, to fill the vacancy; he was also appointed to the Audit, Compensation, and Nominating and Corporate Governance Committees as Chair of Audit and Compensation. Mr. Rossetti qualifies as an independent director under OTCQB standards and is financially sophisticated for the Audit Committee, with no prior arrangements, family relationships, or disclosable transactions.

• ·Mr. Rossetti's experience includes institutional capital markets, investment banking advisory, retail finance, IPOs, SPAC transactions, private placements, and bridge financings.
• ·No compensatory arrangement entered into with Mr. Rossetti at this time; future arrangements to be disclosed if applicable.
• ·Filing includes Exhibit 17.1: Resignation Letter of J. Mark Hemmann.

03-04-2026

CitroTech Inc. entered into a Transition Agreement with Stephen Conboy, its former Chief Technology Officer, effective March 31, 2026, transitioning him to an outside advisor role for a 90-day period ending June 30, 2026, with monthly payments of $10,000 and product advances up to $200,000. Post-transition, Conboy gains exclusive sales rights for specified products in a Tahoe-area territory subject to minimum gross sales thresholds of $500,000 in 2026 and $2,000,000 thereafter, along with equity provisions triggered by $10,000,000 financing or revenue milestones. His resignation from the CTO position was not due to any disagreements with the company.

• ·Transition Period: March 31, 2026 to June 30, 2026 (90 days)
• ·Exclusive sales territory: near North Lake Tahoe, South Lake Tahoe, and Truckee, California
• ·Agreement includes broad release of claims, confidentiality, non-disclosure, restrictive covenants, and non-disparagement provisions
• ·Post-transition affiliate agreement to be negotiated for commissions on net sales in defined territory

03-04-2026

On March 31, 2026, Vertro, Inc., a wholly-owned subsidiary of Inuvo, Inc., entered into an Extension Amendment to its Google Services Agreement with Google LLC, effective April 1, 2026. The amendment extends the agreement term by three additional months, with the new expiration date of June 30, 2026. No financial terms or performance metrics were disclosed in the filing.

• ·Original Google Services Agreement effective January 1, 2024.
• ·Exhibit 10.1 filed with redactions for confidential information.

03-04-2026

T3 Defense Inc. (formerly Nukkleus Inc., ticker DFNS) entered into a Cancellation Agreement on March 31, 2026, fully terminating its $16,000,000 indebtedness obligation to wholly-owned subsidiary Star 26 Capital, Inc., effective immediately at no cost, no dilution, and with no offsetting obligations. This action follows the restructuring of the original acquisition from 51% to 100% ownership under the Amended and Restated Securities Purchase Agreement dated September 15, 2025, eliminating the prior rationale for the debt as Star 26 now operates fully under T3's control. The company retains full ownership of Star 26 and all its assets, operations, and subsidiaries.

• ·The original indebtedness was structured for a contemplated 51% acquisition of Star 26 but became unnecessary after full 100% ownership.
• ·The Cancellation Agreement is filed as Exhibit 10.50.
• ·Company securities: Common Stock (DFNS) and Warrants (DFNSW) listed on Nasdaq Stock Market LLC.
• ·Filing date: April 3, 2026; Event date: March 31, 2026.

03-04-2026

Forian Inc. (Nasdaq: FORA) entered into a definitive merger agreement to be acquired in an all-cash transaction by a consortium led by Max Wygod, Chairman and CEO, for $2.17 per share, valuing the company's equity at approximately $68 million—a 22.6% premium to the unaffected closing price as of August 22, 2025. The transaction has no financing condition, was unanimously approved by the Board on the Special Committee's recommendation, and is expected to close in Q2 2026, after which Forian will delist from Nasdaq and operate as a private company. The Board recommends stockholders tender their shares.

• ·Special Committee formed on August 25, 2025, advised by Houlihan Lokey (financial) and Potter Anderson & Corroon LLP (legal).
• ·Transaction not subject to financing condition; Consortium committed funding via commitment letter.
• ·Forian to continue operations under current leadership, headquarters in Newtown, PA, and Forian brand post-close.

03-04-2026

On March 30, 2026, Daniel Schurr resigned from the CHS Inc. Board of Directors, effective immediately, to accept a seat on the board of Nationwide Mutual Insurance Company. Schurr had served as a director since 2006, including as Chair from 2017 to December 2025, representing Region 7 (Alabama, Arkansas, Florida, Georgia, Iowa, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, and Tennessee). A replacement Region 7 director will be elected by CHS members at the 2026 Annual Meeting.

• ·Region 7 includes: Alabama, Arkansas, Florida, Georgia, Iowa, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, Tennessee

03-04-2026

On March 31, 2026, the Board of Directors of Global-Smart.Tech Inc. appointed Leonel Agustin Peleriti as an Independent Director, effective immediately. Mr. Peleriti, a former Technology Solutions Analyst at Mercado Libre (2020-2023) with a Bachelor’s degree in Information Systems Engineering from the National University of Córdoba, was confirmed to meet OTC Markets independence standards with no material conflicts, family relationships, or transactions exceeding $120,000. The Company is an emerging growth company with principal offices in Tivat, Montenegro.

• ·Company incorporated in Wyoming (IRS EIN: 98-1664763; Commission File Number: 000-56781)
• ·Principal executive offices: Yehor Rodin Kava b.b., 85320, Tivat, Montenegro; Phone: +1-205-2165924
• ·No securities registered pursuant to Section 12(b) of the Act
• ·No family relationships between Mr. Peleriti and any directors or executive officers
• ·No material plan, contract, or arrangement involving the new director in connection with the appointment